29
Introduction to San Diego Biotech http://sdbn.org/transition Nov 14th, 2009 Transitions to Industry Event

Transitions to Industry

Embed Size (px)

DESCRIPTION

Introduction Transitions to Industry event sponsored by San Diego Postdoctoral Training Consortium, given by Mary Canady Nov. 14th 2009.

Citation preview

Page 1: Transitions to Industry

Introduction to San Diego Biotech

http://sdbn.org/transition

Nov 14th, 2009 Transitions to Industry Event

Page 2: Transitions to Industry

Who am I?

Scientist at heartWent to the ‘dark side,’ MarketingLoves to connect & helpWants to change the worldLoves to be interrupted

Page 3: Transitions to Industry
Page 4: Transitions to Industry

HybritechSan Diego’s first BiotechFounded in 1978DiagnosticsHybritech ‘alumni’ founded

Ligand, Dura, Gensia, Neurocrine Biosciences, Immune Response Corp., Viagene, Gen-Probe, Nanogen and Genoptix, 175 total

SD Region home to ~500 companiesAcademic centers ‘fuel’ growthCONNECT, Biocom, SDBN, other orgs serve

Page 5: Transitions to Industry

San Diego BiotechArea Products Customers Examples No. in SD

County*Life Sciences Research

Tools & Services

Research Scientists Invitrogen, Millipore

278

Medical Device, Diagnostics

Point of Care Tools or Tests

Clinical Researchers BioSite 74

Biotech/Ag Biofuels, Food & Consumer Products or Additives

Investors/Partners, Consumers

Sapphire Energy, Verenium

53**

Biotech/Pharma Therapeutics Investors/Partners, Consumers

Amylin, Intellikine

133

*Data from Biocom’s Product Database**Additional data provided by CleanTECH San Diego

Page 6: Transitions to Industry

Life Sciences

Products: Research Tools & ServicesProduct Cycle: 1-2 yrRegulated? NoCustomers: Research ScientistsExample: Invitrogen# in San Diego: 278Pay: $Stability: ++

Page 7: Transitions to Industry

Medical Device, Diagnostics

Products: Point of Care Tools or TestsProduct Cycle: 2-4 yrRegulated? YesCustomers: Clinical ResearchersExample: BioSite# in San Diego: 74Pay: $$Stability: ++

Page 8: Transitions to Industry

Biotech/AgProducts: Biofuels, Food & Consumer Products or AdditivesProduct Cycle: 2-8 yrsRegulated? YesCustomers: Investors/Partners, ConsumersExample: Sapphire Energy, Verenium# in San Diego: 53Pay: $$Stability: ++

Page 9: Transitions to Industry

Biotech/Pharma

Products: TherapeuticsProduct Cycle: 5-10 yrsRegulated? YesCustomers: Investors/Partners, ConsumersExample: Trius# in San Diego: 133Pay: $$$Stability: +

Page 10: Transitions to Industry

Where is Biotech?

New Yo

rk

San Fr

ancis

co, C

A

San Dieg

o & Lo

s Ange

les

Boston, M

A

San Dieg

o

Wash

ington, D

C

Raleigh

-Durh

am

Seatt

le, W

A0

20,000

40,000

60,000

80,000

100,000

120,000

140,000

Numbers calculated from LinkedIn users classified as Biotech, Pharma, Nanotech, Medical DeviceActual numbers may be as much as 2XTotal Globally: 1.7M US: 1M

Page 11: Transitions to Industry

Trends

Funding/Partnerships going to later-stage companiesDecrease in funding: more pressure to apply scienceTrend towards more outsourcing—not all overseasGreen tech seems promising, long term impact unclearSD Biotech IPO last week: Trius Therapeutics

Page 12: Transitions to Industry

It’s All About the Product

What will the product be?How will we make it?How will we meet legal & regulatory guidelines?How will we meet quality standards?How will we sell it?How will we support it?

Page 13: Transitions to Industry

What will the product be?

Marketing*, Business Development*, R&D*, Patent Agent*

Successful companies make unique products that customers need

Market ResearchCompetitive AnalysisTechnology/Intellectual Property Analysis

Skills requiredCommunication, analysis

Your edgeKnowledge of latest science

Page 14: Transitions to Industry

How will we make it?

R&D, Project Management, QA/QC*

Turning an idea into a stable product

Skills requiredTeamwork

Your edgeKnowledge of latest toolsDevelopment of ‘products’ during research

Page 15: Transitions to Industry

How will we meet legal & regulatory guidelines?

Regulatory Affairs*, LegalSet up internal guidelinesCommunicate with external organizations such as FDA

Skills requiredAttention to detailCommunication

Your edge(Likely need to work up to these positions)

Page 16: Transitions to Industry

How will we meet quality standards?

QA/QC*Set up framework & policiesTest products

Skills requiredAttention to detail

Your edgeDevising reproducible experimental protocols

Page 17: Transitions to Industry

How will we sell it?

Marketing*, Sales*, Technical Writing*

Communicating value

Skills requiredCreativityDistilling

Your edgeNetwork/rapport with scientists

Page 18: Transitions to Industry

How will we support it?

Technical Service, Application Specialist*, Technical Writing*

Help customers use products

Skills requiredTechnical knowledge of products & research area

Your edgeFamiliarity with research area or products

Page 19: Transitions to Industry

What’s Your Career Gene?

R&D is one of many optionsOther avenues may afford more flexibilityLook to other interests, proclivities

Page 20: Transitions to Industry

How Did I End Up Here?

1990-2000: Grad school, PostdocProtein Structures, VisualizationsConnecting scientists sociallyDeveloped Lab website

2000-2007: Invitrogen, EMD, small biotech

Fell in love with MarketingDeveloped web-based tools for scientists

2008: Founded Comprendia, SDBNFull Story: http://bit.ly/39Y6We

Page 21: Transitions to Industry

MaryFounder, Comprendia/SDBN, Marketing/Business DevelopmentAverage Day

Blog about interesting biotech news or researchHelp biotech clients develop strategies & tactics for growthLearn from social media network & interact

Greatest satisfaction: Connecting people/ideasGreatest asset: I love my job.

Page 22: Transitions to Industry

KarinDirector of Regulatory Affairs, BiositeAverage Day

Research of diagnostic products on market—how did they fare with FDA?Meetings with project teams, making sure they’re gathering the correct data for FDALearning about patient or doctor issues with products and deciding what actions to take

Greatest satisfaction: Using her background in science and marketing to bring new products to marketGreatest asset: Very stable, sought after niche

Page 23: Transitions to Industry

SteveDrug Discovery Specialist, Millipore, SalesAverage Day

Meet with drug discovery senior directors

Understand their problemsFind ways to help

Team meetings

Greatest satisfaction: Helping scientistsGreatest asset: understanding of drug discovery, great network

Page 24: Transitions to Industry

AmySr. Science Marketing Writer, IlluminaAverage Day

Writing projects: surveying literature and other materials to develop engaging, relevant marketing contentProject Meetings, e.g.:

Product teamsCorporate/Marketing Strategy

Communicating & collecting information

Greatest satisfaction: Explaining cool, complex technologiesGreatest asset: ‘I am good at what I do, and it’s fun’

Page 25: Transitions to Industry

How Can I Compete?

NetworkOnline & f2fEspecially with coworkers

OnlineLinkedIn

Online resumeConnect to othersJoin groups

Link to me!

Page 27: Transitions to Industry

Take an Active Role

Learn from othersSocial Media is a perfect tool

BlogTweet

You can start on the SDBN Blog!

http://sdbn.org/iwannablog

Page 28: Transitions to Industry
Page 29: Transitions to Industry

ResourcesItem LInk

Social Media for Scientists Pt. 1 http://sdbn.org/sdsms

Social Media for Scientists Pt. 2 http://sdbn.org/sms

SDBN Calendar http://sdbn.org/calendar

SDBN Jobs http://sdbn.org/jobs

Xconomy http://xconomy.com